|
"Anticancer agents based on prevention of protein prenylation," S. D. Rose, S. R. Ottersberg, K. J. Okolotowicz, D. E. Robinson, R. Hartman, and S. Lefler, U.S. Patent No. 7,344,851 (2008)
"Emollient, Humectant, and Fluorescent alpha,beta-Unsaturated Thiol Esters for Long-Acting Skin Applications," C. Robinson, R. F. Hartman and S. D. Rose, Bioorg. Chem. 36 265-270 (2008)
"Conjugated nitro alkene anticancer agents based on isoprenoid metabolism," S. D. Rose, K. J. Okolotowicz, R. F. Hartman, & J. Houtchens, U.S. Patent No. 7,312,191 (2007)
"Kinetics and Mechanism of the Addition of Nucleophiles to α,β-Unsaturated Thiol Esters," R. F. Hartman and S. D. Rose, J. Org. Chem. 71 6342−6350 (2006)
"Anticancer Agents Based on Regulation of Protein Prenylation," S. D. Rose, S. R. Lefler, S. R. Ottersberg, A. Y. Kim, K. J. Okolotowicz, and R. F. Hartman, U.S. Patent Number 7,019,031 (2006)
"Anticancer Agents Based on Prevention of Protein Prenylation," S. D. Rose, S. R. Ottersberg, K. J. Okolotowicz, D. E. Robinson, R. Hartman, and S. Lefler, U.S. Patent Number 7,012,097 (2006)
"1,3-Bis(3,4,5-trimethoxyphenyl)-2,3-epoxypropanone: an anticancer chalcone epoxide," T. Cuthbertson, T. L. Groy, and S. D. Rose, Acta Crystallographica E61 o4300-o4302 (2005)
"Anticancer Agents Based on Prevention of Protein Prenylation," S.D. Rose, S.R. Ottersberg, K.J. Okolotowicz, D.E. Robinson, R.F. Hartman and S. Lefler, U.S. Patent No. 6,576,436 (2003)
"Inactivation of Protein Farnesyltransferase by Active-Site-Targeted Dicarbonyl Compounds," K.J. Okolotowicz, W.-J. Lee, R.F. Hartman, A.Y. Kim, S.R. Ottersberg, D.E. Robinson Jr., S.R. Lefler and S.D. Rose, Arch. Pharm., Pharm. Med. Chem 334 194-202 (2001)
"Long-Acting, Chemical-Resistant Skin Emollients, Moisturizers, and Strengtheners," S. D. Rose, R. F. Hartman, C. Chow, C. M. Rose, and K. D. Rose, U.S. Patent No. 6,284,258 (2001)
|
